Pulse Biosciences shares surge 2.34% afterhours due to rights offering closure with oversubscription and $83M raised.
AinvestWednesday, Jul 3, 2024 4:32 pm ET

Pulse Biosciences, Inc. experienced a 2.34% increase in after-hours trading following the announcement of the successful closing of its rights offering. The company raised approximately $83 million, exceeding the $60 million target by 138%, indicating strong investor support. This positive development, with participation from over 800 accounts, including Executive Chairman Robert Duggan, contributed to the stock's uplift during the after-hours session. The rights offering's success demonstrates the confidence in Pulse Biosciences' CellFX® Nanosecond Pulsed Field Ablation™ technology and its potential for growth.

Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
Comments
No comments yet